Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions
Melbourne (Australia) and Indianapolis, IN (United States) | June 23, 2026
Telix today announces an educational webinar exploring the unmet needs in neurologic oncology (specifically glioma and glioblastoma) and how theranostics may help address these.
David N. Cade, MD, Telix Group Chief Medical Officer will provide a clinical update, which will be followed by a fireside chat with Nelleke Tolboom, MD, Nuclear Medicine physician and academic faculty member at UMC Utrecht (Netherlands) and Josef Pichler, MD, Head of the Neuro-oncological Center at Kepler University Hospital Linz (Austria).
The presentation will be followed by Q&A with Dr. Cade and Richard Valeix, CEO, Telix Therapeutics.
Webinar date and time:
EDT: Monday June 29, 2026, 5:00 p.m.
AEST: Tuesday June 30, 2026, 7:00 a.m.
Participants can register for the webinar at the following link: